您的位置: 首页 > 农业专利 > 详情页

Antibodies and antibody-drug conjugates specific for CD123 and uses thereof
专利权人:
Pfizer Inc.
发明人:
CHARATI, Manoj Baburao,HAN, Yoon-Chi,KATRAGADDA, Madan,PICHÉ-NICHOLAS, Nicole Melissa,TUMEY, Lawrence Nathan
申请号:
AU2018357221
公开号:
AU2018357221A1
申请日:
2018.10.16
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
The present invention provides antibodies that specifically bind to CD123. The invention further relates to immunoconjugates (e.g., antibody-drug conjugates, or ADCs) comprising such antibodies, antibody encoding nucleic acids, and methods of obtaining such antibodies. The invention further relates to therapeutic methods for use of these antibodies and ADCs for the treatment of a condition associated with cells expressing CD123 (e.g., cancer or autoimmune disease).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充